Muscle‐specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism
The Journal of Physiology · 2025
DOI: 10.1113/jp288854 ↗At a glance
Journal article in The Journal of Physiology, 2025. Written by Kaspar W Persson and 7 co-authors. Institution: August Krogh Section for Human and Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, …. Major MEDLINE topics: Axin Protein, Mechanistic Target of Rapamycin Complex 1, Glucose, Muscle, Skeletal. Cited 1 times so far (Crossref); 25 references. The full text is freely available (open access, CC BY 4.0). Funded by: Novo Nordisk Fonden, Lundbeck Foundation.
Abstract (original language)
AMP‐activated protein kinase (AMPK) and mechanistic target of rapamycin complex 1 (mTORC1) are crucial kinase signalling hubs that regulate the balance between catabolism and anabolism in skeletal muscle. The scaffold protein AXIN1 has been proposed to regulate the switch between these pathways and be required for GLUT4 translocation in skeletal muscle and adipocyte cell lines. Muscle‐specific AXIN1 knockout (KO) mice exhibit no discernable phenotype, possibly due to compensation by AXIN2 upon AXIN1 loss. Thus we generated and characterized muscle‐specific inducible AXIN1 and AXIN2 double knockout (dKO) mice. Surprisingly AXIN1/2 dKO mice displayed normal AMPK and mTORC1 signalling and glucose uptake in response to 5‐aminoimidazole‐4‐carboxamide ribonucleotide (AICAR), insulin and in situ muscle contraction. These findings suggest that AXIN proteins are not essential for the regulation of AMPK and mTORC1 signalling or glucose uptake in skeletal muscle. This study challenges the previously indicated critical roles of AXIN1 in exercise‐stimulated AMPK activation and GLUT4‐mediated glucose uptake in skeletal muscle. image Key points Phenotyping of tamoxifen‐inducible muscle‐specific AXIN1/2 double knockout (dKO) mice. We find no evidence for AXIN‐dependent AMPK or mTORC1 regulation in skeletal muscle by insulin, AMPK activation or contraction. Glucose uptake regulation by insulin and AMPK activation is normal in AXIN1/2 dKO mice.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- August Krogh Section for Human and Molecular Physiology, Department of Nutrition, Exercise and Sports, Faculty of Science, University of Copenhagen, Copenhagen, Denmark.
- Exercise Science Laboratory, Faculty of Medicine, Universidad Finis Terrae, Santiago, Chile.
ORCID profiles: Thomas E Jensen
Funding
- Novo Nordisk Fonden
- Lundbeck Foundation
Cite
APA
Persson, K. W., Meneses-Valdés, R., Andersen, N. R., Pedersen, F. S., Gallero, S., Hesselager, S. A., Henriquez-Olguin, C., & Jensen, T. E. (2025). Muscle‐specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism. The Journal of Physiology. https://doi.org/10.1113/jp288854
Vancouver
Persson KW, Meneses-Valdés R, Andersen NR, Pedersen FS, Gallero S, Hesselager SA, et al. Muscle‐specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism. The Journal of Physiology. 2025. doi:10.1113/jp288854
BibTeX
@article{Persson2025,
author = {Persson, Kaspar W and Meneses-Valdés, Roberto and Andersen, Nicoline R and Pedersen, Frederik S and Gallero, Samantha and Hesselager, Sofie A and Henriquez-Olguin, Carlos and Jensen, Thomas E},
title = {Muscle‐specific AXIN1 and AXIN2 double knockout does not alter AMPK/mTORC1 signalling or glucose metabolism},
journal = {The Journal of Physiology},
year = {2025},
doi = {10.1113/jp288854}
}
EUVIMED